Angiotensin Receptors and Renal Function
作者： David P. Chan , John C. Burnett
DOI: 10.1007/978-1-4615-2464-9_19
关键词: Angiotensin-converting enzyme 、 Renal blood flow 、 Internal medicine 、 Kidney 、 Endocrinology 、 Biology 、 Angiotensin receptor 、 Angiotensin II 、 Receptor 、 Angiotensin II receptor type 1 、 Regulator
摘要: Angiotensin II (ANG II) is an important and potent regulator of renal function. With the discovery specific types angiotensin receptors availability receptor antagonists, a body information evolving to describe function these receptors. Along with insights in physiological actions ANG on receptors, variability type localization within system has been described. In addition, maturational difference exists development kidney.
springer.com
sci-hub.st 参考文章(33)
William F. Herblin, Andrew T. Chiu, Dale E. McCall, Robert J. Ardecky, David J. Carini, John V. Duncia, Lori J. Pease, Pancras C. Wong, Ruth R. Wexler, Alexander L Johnson, Pieter B.M.W.M. Timmermans, Angiotensin II receptor heterogeneity. American Journal of Hypertension. ,vol. 4, ,(1991) , 10.1093/AJH/4.4.299S
L. A. Sechi, E. F. Grady, C. A. Griffin, J. E. Kalinyak, M. Schambelan, Distribution of angiotensin II receptor subtypes in rat and human kidney American Journal of Physiology-renal Physiology. ,vol. 262, ,(1992) , 10.1152/AJPRENAL.1992.262.2.F236
Martin G. Cogan, Ming-Hong Xie, Fu-Ying Liu, Pancras C. Wong, Pieter B.M.W.M. Timmermans, Effects of DuP 753 on proximal nephron and renal transport. American Journal of Hypertension. ,vol. 4, ,(1991) , 10.1093/AJH/4.4.315S
J. E. Hall, Control of sodium excretion by angiotensin II: intrarenal mechanisms and blood pressure regulation American Journal of Physiology-regulatory Integrative and Comparative Physiology. ,vol. 250, ,(1986) , 10.1152/AJPREGU.1986.250.6.R960
R. R. Wexler, A. L. Johnson, D. J. Carini, P. C. Wong, P. B. M. W. M. Timmermans, A. T. Chiu, W. A. Price, J. V. Duncia, Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent. Journal of Pharmacology and Experimental Therapeutics. ,vol. 252, pp. 719- 725 ,(1990)
Kenneth L. Clark, Mark J. Robertson, G. Michael Drew, Role of angiotensin AT1 and AT2 receptors in mediating the renal effects of angiotensin II in the anaesthetized dog British Journal of Pharmacology. ,vol. 109, pp. 148- 156 ,(1993) , 10.1111/J.1476-5381.1993.TB13545.X
Pieter B.M.W.M. Timmermans, Pancras C. Wong, Andrew T. Chiu, William F. Herblin, Nonpeptide angiotensin II receptor antagonists Trends in Pharmacological Sciences. ,vol. 12, pp. 55- 62 ,(1991) , 10.1016/0165-6147(91)90498-H
Raymond S.L. Chang, Victor J. Lotti, Angiotensin receptor subtypes in rat, rabbit and monkey tissues: relative distribution and species dependency. Life Sciences. ,vol. 49, pp. 1485- 1490 ,(1991) , 10.1016/0024-3205(91)90048-G
D. P. Chan, E. K. Sandok, L. L. Aarhus, D. M. Heublein, J. C. Burnett, Renal-specific actions of angiotensin II receptor antagonism in the anesthetized dog American Journal of Hypertension. ,vol. 5, pp. 354- 360 ,(1992) , 10.1093/AJH/5.6.354
Naoharu Iwai, Tadashi Inagami, Regulation of the expression of the rat angiotensin II receptor mRNA Biochemical and Biophysical Research Communications. ,vol. 182, pp. 1094- 1099 ,(1992) , 10.1016/0006-291X(92)91844-G